These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30072154)

  • 21. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft.
    Zhang ZZ; Zhang SZ; Zhou HM; Fan YQ; Liu MH; Zhong XB; Yang DY; Guo Y; Zhuang XD; Liao XX
    Eur J Clin Invest; 2021 Jan; 51(1):e13405. PubMed ID: 32926588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
    Gupta S; Belley-Côté EP; Rochwerg B; Bozzo A; Panchal P; Pandey A; Mbuagbaw L; Mehta S; Schwalm JD; Whitlock RP
    Medicine (Baltimore); 2019 Aug; 98(34):e16880. PubMed ID: 31441862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery.
    Nei SD; Wamsley KS; Mara KC; Stulak JM; Zieminski JJ
    Clin Appl Thromb Hemost; 2022; 28():10760296221124902. PubMed ID: 36112808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis.
    Raheja H; Garg A; Goel S; Banerjee K; Hollander G; Shani J; Mick S; White J; Krishnaswamy A; Kapadia S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):783-791. PubMed ID: 29516608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
    J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.
    Gargiulo G; Ariotti S; Santucci A; Piccolo R; Baldo A; Franzone A; Magnani G; Marino M; Esposito G; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1780-9. PubMed ID: 27544007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting.
    Choi KH; Song YB; Jeong DS; Jang YH; Hong D; Lee SY; Youn T; Bak M; Min KM; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Chung SR; Cho YH; Sung K; Kim WS; Gwon HC; Lee YT
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):517-526. PubMed ID: 33075126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting.
    Agarwal N; Mahmoud AN; Patel NK; Jain A; Garg J; Mojadidi MK; Agrawal S; Qamar A; Golwala H; Gupta T; Bhatia N; Anderson RD; Bhatt DL
    Am J Cardiol; 2018 Jan; 121(1):32-40. PubMed ID: 29122278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
    Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T
    Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
    Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.
    Chakos A; Jbara D; Singh K; Yan TD; Tian DH
    Ann Cardiothorac Surg; 2018 Sep; 7(5):577-585. PubMed ID: 30505741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis.
    Navarese EP; Wernly B; Lichtenauer M; Petrescu AM; Kołodziejczak M; Lauten A; Frediani L; Veulemanns V; Wanha W; Wojakowski W; Lesiak M; Ferrante G; Zeus T; Tantry U; Bliden K; Buffon A; Contegiacomo G; Jung C; Kubica J; Pestrichella V; Gurbel PA
    Int J Cardiol; 2018 Oct; 269():292-297. PubMed ID: 30045826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
    Camaro C; Damen SA; Brouwer MA; Kedhi E; Lee SW; Verdoia M; Barbieri L; Rognoni A; van T Hof AW; Ligtenberg E; de Boer MJ; Suryapranata H; De Luca G
    Am Heart J; 2016 Aug; 178():37-44. PubMed ID: 27502850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis.
    Gupta S; Belley-Cote EP; Panchal P; Pandey A; Basha A; Pallo L; Rochwerg B; Mehta S; Schwalm JD; Whitlock RP
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):354-363. PubMed ID: 32772110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.